Phrase Health Secures NIH SBIR Funding to Advance Innovative Analytics Solutions
Phrase Health, Inc. secures $2M NIH SBIR grant to develop innovative EHR workflow management solutions, advancing patient care through data-driven, continuous improvement.
Delve Health Partners with Strados Labs to Enhance Remote Patient Monitoring in Clinical Trials
Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement
Proposed merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for serious, rare genetic skin diseases for which there are no FDA-approved therapies
Combined company is expected to have approximately $80.5 million of cash and cash equivalents at closing, including approximately $78.9 million from an oversubscribed private financing with participation from a syndicate of leading healthcare-dedicated investors, which is expected to provide cash runway into the second half of 2027
Anticipated cash and cash equivalents are expected to fund combined company through multiple clinical trial milestones, including pivotal Phase 3 clinical trial results from a single-arm, baseline-controlled clinical trial of QTORIN™3.9% rapamycin anhydrous gel (QTORIN™ rapamycin) for the treatment of microcystic lymphatic malformations currently being conducted under FDA’s Breakthrough Therapy Designation and Fast Track Designation programs
QTORIN™ rapamycin has the potential to be the first approved therapy and standard of care in the U.S. for microcystic lymphatic malformations and cutaneous venous malformations, if approved
Companies to host joint webcast on Wednesday, July 24 at 8:30am ET
Accelerated Bio and Pluristyx create Clinical Grade Induced Pluripotent Stem Cells from Reprogramming Human Trophoblast Stem Cells
Science: There Will Be Blood
Is mimicking the cells that carry hemoglobin the key to a blood substitute?
The UM BioPark is a beacon for early-stage technology ventures
The research park’s perfectly matched location and array of startup-supporting resources makes it an invaluable pillar for a growing number of life science startups — and the entire Maryland ecosystem.
Wellsheet AI-Powered Smart EHR UI Delivers Usability and ROI
– 94% of clinicians recommend for chart review
– 6.3% reduction in length of stay
– 8X+ ROI in first year, delivering ~$8M savings per hospital
– 40%+ reduction in time spent in the EHR
IVIEW Therapeutics Inc. Announces Dosing of First Patient in Phase 1/2 Clinical Trial of IVW-1001 for Dry Eye Disease
Accelerated Biosciences Announces License of its Human Trophoblast Stem Cells (hTSC) to Agathos Biologics for Development of Ethically Sourced Research and Biomanufacturing Platforms